Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte.
Lee
Yong-Ho
YH
Diabetes and Metabolism Translational Medicine Unit, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Pratley
Richard E
RE
D017667:Adipocytes / Q000378:metabolism* / Q000473:pathology; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control; D016207:Cytokines / Q000378:metabolism; D048909:Diabetes Complications / Q000378:metabolism; D003920:Diabetes Mellitus / Q000209:etiology / Q000378:metabolism; D050171:Dyslipidemias / Q000150:complications / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000209:etiology; D007249:Inflammation / Q000209:etiology* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D018836:Inflammation Mediators / Q000378:metabolism; D007333:Insulin Resistance; D050152:Intra-Abdominal Fat / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D009765:Obesity / Q000150:complications* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D012307:Risk Factors
D016207:Cytokines; D018836:Inflammation Mediators